The Use of a Dynamic Sustained Compression Intramedullary Nail for Tibiotalocalcaneal Arthrodesis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04831645|
Recruitment Status : Recruiting
First Posted : April 5, 2021
Last Update Posted : May 25, 2021
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
|Condition or disease||Intervention/treatment|
|Ankle Arthritis Arthritis Foot||Device: DynaNail Procedure: Tibiotalocalcaneal Arthrodesis|
This study is a collaborative effort between the Orthopedic Foot and Ankle Center, MedShape, Inc, and CurveBeam. This is a prospective investigation to assess the clinical outcomes of patients with a tibiotalocalcaneal arthrodesis with the Sustained Dynamic Compression Intramedullary Nail (DynaNail), including longitudinal assessment with weight-bearing CT. The investigators plan to enroll 45 patients. No placebo control will be used, as there is no other IM nail available capable of providing sustained compression. Additionally, given that many patients receiving this treatment have had prior failed treatments and face poor alternatives such as amputation, using a prior-generation IM nail as a control treatment would be unethical.
This is a prospective, single-group study. Patients of the Orthopedic Foot and Ankle Center who are scheduled to undergo TTC arthrodesis will be screened for eligibility and informed consent will be obtained from those who meet the inclusion/exclusion criteria. Subjects will be assessed pre-operatively and then at five post-operative intervals: 1 week, 6 weeks, 3 months, 6 months, and 12 months. A WBCT scan will be obtained at each interval.
Selection of Subjects:
Patients will be identified in the clinic by an attending orthopaedic foot and ankle surgeon or his/her physician assistant based on clinical exam and radiographic findings. Patients will be screened for eligibility by the research coordinator/ key personnel in close coordination with the surgeon and co-investigator.
After informed consent, the patients will be asked to complete patient reported outcomes questionnaires that are part of the SOS Registry associated with function and pain, including VAS, VR-12, FFI-R, FAAM, AOS, and AOFAS. The patients will also be asked to provide information related to prior medical history (including potential co-morbidities associated with non-union, i.e. tobacco usage, neuropathy, renal disease, obesity, etc.) and surgical history of the subject lower extremity.
The following surgical procedure is standard of care. The surgical procedure will involve both tibiotalar and talocalcaneal joint preparation through any approach (lateral, posterior, anterior with sinus tarsi). The use of supplemental bone graft is at the discretion of the treating surgeon but must be documented. The MedShape DynaNail will then be inserted according to the manufacturer's technique. The patient will be placed in a short leg splint and kept non-weight bearing initially. The patient will be discharged from the hospital when medically ready. Weight-bearing will start at seven weeks post-surgery.
Follow-Up Visits and Questionnaires:
The patient will return to clinic for visits at the following intervals after surgery: 1 week, 6 weeks, 3 months, 6 months, and 12 months. At each of these time points, a clinical exam will be conducted, and SOS patient questionnaires will be administered, as well as a radiographic and clinical follow-up form. Additionally, radiograph and weight-bearing CT imaging will be obtained of both the ankle and subtalar joints. At 3 months and 12 months post-op, all X-ray and CT images will be de-identified, burned to a DVD, and copies will be sent to both co-sponsors.
|Study Type :||Observational|
|Estimated Enrollment :||45 participants|
|Official Title:||The Use of a Dynamic Sustained Compression Intramedullary Nail for Tibiotalocalcaneal Arthrodesis|
|Actual Study Start Date :||May 24, 2021|
|Estimated Primary Completion Date :||May 24, 2024|
|Estimated Study Completion Date :||May 24, 2024|
- Device: DynaNail
Utilization of a novel dynamic compression pseudoelastic intramedullary nail
- Procedure: Tibiotalocalcaneal Arthrodesis
Tibiotalocalcaneal (TTC) arthrodesis with a novel dynamic compression intramedullary nail.Other Names:
- Subtalar Arthrodesis
- Tibiotalar Arthrodesis
- Fusion [ Time Frame: Pre-Operative to 1 year post-surgery ]Joint Fusion, as measured by radiographs and CT scans. Fusion rates will be assessed based on varying CT fusion areas. Fusion rates based on X-Ray vs CT assessment will also be compared. CT fusion rates based on varying fusion areas will be compared with PROM data to assess which fusion area actually corresponds to increased function and reduced pain.
- VAS [ Time Frame: Pre-Operative up to one year post-surgery ]Visual Analog Scaled (VAS) - Rates the intensity of pain from 0 - 10 with 10 being the worst pain possible and 0 being no pain.
- VR-12 [ Time Frame: Pre-Operative up to one year post-surgery ]The Veterans RAND 12 Item Health Survey (VR-12, formerly called the Veterans SF-12) was developed from the Veterans RAND 36 (VR-36, formerly called the Veterans SF-36), which was modified from the original MOS SF-36. The VR-12 measures Physical functioning (PF), social functioning (SF), role limitation due to physical problems (RP), role limitation due to emotional problems (RE), mental health (MH), energy and vitality (VT), bodily pain (BP) and general perception of health (GH). Standard based scoring (sometimes called norm based scoring) is used to calculate the physical component summary (PCS) and mental component summary (MCS) for both measures. The PCS and MCS are standardized using a t-score transformation and normed to a US population at a score of 50 and a standard deviation of 10. Higher scores indicate better health.
- FFI-R [ Time Frame: Pre-Operative up to one year post-surgery ]Foot Function Index-Revised - Measures the impact of foot pathology on function in terms of pain, disability, and activity restriction. The score is a percentage. The higher the score, the greater the disability.
- FAAM [ Time Frame: Pre-Operative up to one year post-surgery ]Foot and Ankle Ability Measure - Measures patient capacity for sports and activities of daily living (ADL). The final score is a percentage. The higher final score represents a higher level of physical function.
- AOS [ Time Frame: Pre-Operative up to one year post-surgery ]Ankle Osteoarthritis Scale - Measures pain levels and difficulty performing various activities of daily living. A line-based scale with range from no pain to the worst pain imaginable.
- AOFAS [ Time Frame: Pre-Operative up to one year post-surgery ]American Orthopaedic Foot and Ankle Society Scale - Clinician-based outcome that measures foot/ankle pain, function, and alignment. The lower the score, the greater the disability. The maximum score is 100.
- Automated vs Manual Fusion Assessment [ Time Frame: Up to one year post-surgery ]Fusion area calculation over time will be assessed not only by two clinically-trained reviewers, but also using CurveBeam's automated CubeVue assessment software. Averaged clinician results will be compared with CubeVue-calculated data.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||18 Years and older (Adult, Older Adult)|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||No|
|Sampling Method:||Non-Probability Sample|
- Meets indications for TTC arthrodesis and receives the DynaNail implant
- Able to understand the requirements of the study
- Willing to comply with the study protocol
- Sign an Informed consent
- 18 years of age or older
- Investigator determines that the subject is unlikely to comply with the requirements of the study
- Non-English speaker
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04831645
|Contact: Kenneth M Dupont, Ph.D.||6782353336||Kenneth.email@example.com|
|Contact: Antonio Malloy-McCoy, MPH||614-895-8747 ext firstname.lastname@example.org|
|United States, Ohio|
|Orthopedic Foot and Ankle Center||Recruiting|
|Worthington, Ohio, United States, 43085|
|Contact: Antonio Malloy-McCoy, MPH 614-895-8747 ext 187 email@example.com|
|Contact: Gregory C Berlet, MD firstname.lastname@example.org|
|Principal Investigator: Gregory C Berlet, MD|
|Sub-Investigator: Patrick Bull, DO|
|Sub-Investigator: Terrence M Philbin, DO|
|Sub-Investigator: Mark A Prissel, DPM|
|Sub-Investigator: Christopher F Hyer, DPM|
|Principal Investigator:||Gregory C Berlet, MD||Orthopedic Foot and Ankle Center|
|Responsible Party:||MedShape, Inc|
|Other Study ID Numbers:||
|First Posted:||April 5, 2021 Key Record Dates|
|Last Update Posted:||May 25, 2021|
|Last Verified:||April 2021|
|Individual Participant Data (IPD) Sharing Statement:|
|Plan to Share IPD:||No|
|Studies a U.S. FDA-regulated Drug Product:||No|
|Studies a U.S. FDA-regulated Device Product:||Yes|
|Product Manufactured in and Exported from the U.S.:||No|
Longitudinal Computed Tomography